Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02593006 · ClinicalTrials.gov registry record
Start Time Optimization of Biologics in Polyarticular JIA
A clinical trial, sponsored by Hackensack Meridian Health.
- Completed
- Registry status
- 400
- Enrollment target
NCT02593006 is a clinical trial that has completed, run by Hackensack Meridian Health. The registered enrollment target is 400 participants.
The verdict
NCT02593006 has completed, sponsored by Hackensack Meridian Health.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
STOP-JIA is a PCORI funded prospective observational study which compared the clinical effectiveness and impact on patient reported outcomes of 3 Childhood Arthritis \& Rheumatology Research Alliance (CARRA) consensus derived treatment strategies (CTPs) in new-onset polyarticular JIA (pJIA) patients to answer the critical question of when is the best time to begin biologic medications to achieve the optimal clinical and patient reported outcomes. Because the CARRA Registry will be used for data collection, all patients will be enrolled in the CARRA Registry. The standard of care treatments are chosen by the treating physician and patient/caregiver and are not randomized.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2015-11 |
| Est. Completion | 2019-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02593006
The ClinicalTrials.gov registry entry for NCT02593006 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02593006 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02593006 about?
NCT02593006 is a clinical study titled "Start Time Optimization of Biologics in Polyarticular JIA". STOP-JIA is a PCORI funded prospective observational study which compared the clinical effectiveness and impact on patient reported outcomes of 3 Childhood Arthritis \& Rheumatology Research Alliance (CARRA) consensus derived treatment strategies (CTPs) in new-onset polyarticular JIA (pJIA) patients...
What is the current status of trial NCT02593006?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2015-11. Estimated completion is 2019-09-30.
Who is sponsoring clinical trial NCT02593006?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.